The Ministry of Health has registered a new vaccine for the prevention of COVID-19.

The Ministry of HEALTH announced the registration of a new Russian vaccine for the prevention of CORONAVIRUS infection, called Gam-VLP-Multivac, the ministry told RBK.

The drug was obtained through biotechnology, and the process does not use the SARS-CoV-2 virus , which is pathogenic to humans , they added.

The vaccination with this vaccine will be administered intramuscularly.

The vaccine was developed and manufactured by the N.F. Gamaleya National Research Center for Epidemiology and Microbiology under the Ministry.

They explained that new-generation VLP-based vaccines are created using proteins as an antigen structure that mimics the structure of the virus, making them safer than live virus-based vaccines.

Roman Ivanov , Chairman of the Academic Council of Sirius University and DIRECTOR of the Scientific Center for Translational Medicine, previously reported that the Gamaleya Center will begin custom-made drugs for cancer immunotherapy as early as 2026. He stated that this is due to the progress achieved in the development of mRNA vaccines againstcovid-19 , scientists have gained the opportunity to significantly increase the effectiveness of immunotherapy for cancer patients,” RBC Kuban reported.

ReadPIONERPRODUKT .by inTELEGRAM .